[HTML][HTML] Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases

PR Bharadwaj, KA Bates, T Porter, E Teimouri… - Translational …, 2013 - nature.com
Latrepirdine (Dimebon TM) was originally marketed as a non-selective antihistamine in
Russia. It was repurposed as an effective treatment for patients suffering from Alzheimer's …

Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases

PR Bharadwaj, KA Bates, T Porter, E Teimouri, G Perry… - 2013 - ro.ecu.edu.au
Latrepirdine (Dimebon TM) was originally marketed as a non-selective antihistamine in
Russia. It was repurposed as an effective treatment for patients suffering from Alzheimer's …

[PDF][PDF] Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases

PR Bharadwaj, KA Bates, T Porter, E Teimouri… - neurodegenerative …, 2013 - core.ac.uk
With an ageing population, there is a need for both preventative and disease-modifying
treatments for Alzheimer's disease (AD). Current AD treatments target cognitive decline and …

Latrepirdine: Molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases

PR Bharadwaj, KA Bates, T Porter… - Translational …, 2013 - researchers.mq.edu.au
Latrepirdine (Dimebon TM) was originally marketed as a non-selective antihistamine in
Russia. It was repurposed as an effective treatment for patients suffering from Alzheimer's …

[HTML][HTML] Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases

PR Bharadwaj, KA Bates, T Porter… - Translational …, 2013 - ncbi.nlm.nih.gov
Latrepirdine (Dimebon TM) was originally marketed as a non-selective antihistamine in
Russia. It was repurposed as an effective treatment for patients suffering from Alzheimer's …

Latrepirdine: Molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases

PR Bharadwaj, K Bates, T Porter… - Translational …, 2013 - research-repository.uwa.edu.au
Latrepirdine (Dimebon TM) was originally marketed as a non-selective antihistamine in
Russia. It was repurposed as an effective treatment for patients suffering from Alzheimer's …

Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases

PR Bharadwaj, KA Bates, T Porter… - Translational …, 2013 - pubmed.ncbi.nlm.nih.gov
Latrepirdine (Dimebon (TM)) was originally marketed as a non-selective antihistamine in
Russia. It was repurposed as an effective treatment for patients suffering from Alzheimer's …

[PDF][PDF] Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases

Translational Psychiatry, 2013 - academia.edu
With an ageing population, there is a need for both preventative and disease-modifying
treatments for Alzheimer's disease (AD). Current AD treatments target cognitive decline and …

Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases

PR Bharadwaj, KA Bates, T Porter… - Translational …, 2013 - search.proquest.com
Latrepirdine (Dimebon TM) was originally marketed as a non-selective antihistamine in
Russia. It was repurposed as an effective treatment for patients suffering from Alzheimer's …

Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases.

PR Bharadwaj, KA Bates, T Porter… - Translational …, 2013 - search.ebscohost.com
Latrepirdine (DimebonTM) was originally marketed as a non-selective antihistamine in
Russia. It was repurposed as an effective treatment for patients suffering from Alzheimer's …